Skip to Content

Tools

Meeting Agenda

Agenda: Meeting 2. Prevention and Control of Viral Hepatitis Infections

10:30 AM

Welcome

 

Palmer Beasley, Chair

10:35

Surveillance Strengths and Weaknesses

 

Gary Heseltine, Lead Consultant, Viral Hepatitis Team, Council of State and Territorial Epidemiologists

 

11:15

 

Viral Hepatitis Prevention Policies and Programs, Centers for Medicare and Medicaid (CMS)

 

 

William Rogers, Director of CMS, Physician's Regulatory Issues Team

 

12:00 Noon

Lunch

 

 

1:00 PM

Community Health Centers: Health Resources and Services Administration (HRSA) Policies and Programs

 

 

Tanya Pagan Raggio Ashley, Director, Office of Minority Health and Health Disparities, and Chief Medical Officer, HRSA

 

1:45

Community Health Centers: Prevention and Care

 

Carol Craig, Project Coordinator, National Association of Community Health Centers, Inc.*

 

2:30

 

Hepatitis C Prevention: Harm Reduction

 

Daniel Raymond, Policy Director, Harm Reduction Coalition

 

3:15

Break

 

 

3:30

Global Viral Hepatitis Burden: Implications for the U.S. and CDC Response

 

David Bell, Associate Director for Science and Global Activities, Division of Viral Hepatitis, Centers for Disease Control and Prevention

 

4:15

Global Control Programs and HBV Immunization

 

 

Mark Kane, Former Director of the Children's Vaccine Program, PATH

 

5:00

Adjourn

 

*Ms. Craig was unable to attend the meeting, but submitted her presentation to the committee.

Back to Meeting